ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer

被引：0
|
作者：
Leah K. Winer [1 ]
Austin D. Williams [2 ]
机构：
[1] University of Kentucky,Division of Surgical Oncology, Department of Surgery
[2] Fox Chase Cancer Center,Division of Breast Surgery, Department of Surgical Oncology
来源：
Annals of Surgical Oncology | 2025年 / 32卷 / 2期
关键词：
D O I：
10.1245/s10434-024-16606-w
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：967 / 968
页数：1
相关论文
共 50 条
  • [31] Optimizing HER2-Directed Therapy in Early-Stage Breast Cancer
    Roussos Torres E.T.
    Connolly R.M.
    Current Breast Cancer Reports, 2018, 10 (4) : 262 - 273
  • [32] Pathologic complete response (pCR) in locally advanced HER2+(HER2+) breast cancer (BC) treated with anthracycline-free neoadjuvant therapy
    Somlo, G.
    Waisman, J.
    Yuan, Y.
    Kruper, L.
    Frankel, P.
    Jones, V.
    Lusi, T.
    Schmolze, D.
    Yim, J.
    Hurria, A.
    Mortimer, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [33] De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
    Lorena Gonzalez
    Joanne Mortimer
    Laura Kruper
    Current Breast Cancer Reports, 2021, 13 : 151 - 156
  • [34] PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
    Elisa Agostinetto
    Lieveke Ameye
    Samuel Martel
    Philippe Aftimos
    Noam Pondé
    Christian Maurer
    Sarra El-Abed
    Yingbo Wang
    Malou Vicente
    Saranya Chumsri
    Judith Bliss
    Judith Kroep
    Marco Colleoni
    Fausto Petrelli
    Lucia Del Mastro
    Alvaro Moreno-Aspitia
    Martine Piccart
    Marianne Paesmans
    Evandro de Azambuja
    Matteo Lambertini
    npj Breast Cancer, 8
  • [35] PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
    Agostinetto, Elisa
    Ameye, Lieveke
    Martel, Samuel
    Aftimos, Philippe
    Ponde, Noam
    Maurer, Christian
    El-Abed, Sarra
    Wang, Yingbo
    Vicente, Malou
    Chumsri, Saranya
    Bliss, Judith
    Kroep, Judith
    Colleoni, Marco
    Petrelli, Fausto
    Del Mastro, Lucia
    Moreno-Aspitia, Alvaro
    Piccart, Martine
    Paesmans, Marianne
    de Azambuja, Evandro
    Lambertini, Matteo
    NPJ BREAST CANCER, 2022, 8 (01)
  • [36] HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive Review
    Brown-Glaberman, Ursa
    Dayao, Zoneddy
    Royce, Melanie
    ONCOLOGY-NEW YORK, 2014, 28 (04): : 281 - 289
  • [37] High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy
    Zelnak, Amelia B.
    Nikolinakos, Petros
    Srinivasiah, Jayanthi
    Jonas, William
    Pippas, Andrew
    Liu, Yuan
    Li, Xiaoxian
    Torres, Mylin
    O'Regan, Ruth M.
    CLINICAL BREAST CANCER, 2015, 15 (01) : 31 - 36
  • [38] Genomic copy number alterations (CNA) associated with pCR in HER2-positive (HER2+) early-stage breast cancer (BrCa) patients receiving neoadjuvant trastuzumab (T)
    Walsh, N.
    Gullo, G.
    Maguire, A.
    O'Donovan, N.
    Quinn, C.
    Crown, J.
    CANCER RESEARCH, 2017, 77
  • [39] Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report
    Wade Iams
    Kathyrn Eby Beckermann
    Anne T. Neff
    Ingrid A. Mayer
    Vandana Gupta Abramson
    Medical Oncology, 2013, 30
  • [40] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
12345